Media & Resources

In this episode of Meet the Scientist, we explore IAVI’s efforts in the late-stage development of the MTBVAC TB vaccine candidate

Research literacy learning collaborative led by CASPR brings together health advocates in Africa, linking the science of vaccine development to vaccine advocacy.

IAVI is honored to be co-organizing the 7th Global Forum on TB Vaccines at a time of heightened attention to TB vaccine development and implementation.

New publications in Nature Immunology show primed B cells in mice and non-human primates and germline-targeting immunogens could drive MPER-specific precursors toward bnAbs

Additional evidence advances germline targeting strategy for HIV vaccine development

Lab to close June 30, 2024

Workshop examined high-burden country data needs for future TB vaccine introduction

IAVI leaders to share updates on our emerging infectious disease R&D portfolio and our work to make much-needed vaccines and antibodies globally accessible